Navigation Links
Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
Date:4/28/2009

te cancer, treatment with a mouse equivalent of PGN635 significantly retarded the growth of tumors by more than 90%.

In a separate study, researchers from UT Southwestern Medical Center (Peregrine's academic collaborators) and Affitech demonstrated in in vitro studies that immature dendritic cells cultured in the presence of PGN632 exhibited a significant increase in the production of inflammatory cytokines and chemokines. PGN632 also induced an increase in the expression of cell-surface molecules that are indicative of mature dendritic cells and that assist in antigen presentation functions, as well as in stimulating T-cell proliferation.

"These results demonstrate the efficiency and robustness of Affitech's range of antibody discovery platforms which include CBAS (Cell Based Antibody Screening) in addition to MBAS. They are being applied with increasing success to build proprietary oncology pipelines for both collaborators such as Peregrine and for ourselves," said Dr Martin Welschof, CEO of Affitech AS.

Commenting on the research progress of the antibodies and Peregrine's collaboration with Affitech, Steven King, President and CEO of Peregrine Pharmaceuticals said, "As leaders in the development of anti-PS antibodies for both oncology and anti-viral applications, we are delighted with these promising data for our fully human anti-PS antibodies from Affitech. They are the result of our well-established and highly productive collaboration and we look forward to continuing success in this and other projects."

For more information on Peregrine's anti-PS programs, visit http://www.peregrineinc.com


'/>"/>
SOURCE Affitech AS
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
2. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
3. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
4. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
5. Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
6. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
7. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
8. CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
9. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
10. Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
11. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... forma net operating loss (NOL) guidance and its cash ...  Isis, significantly improved financial results were due in large ... the Company received from its partners.  Isis, pro forma ... 60% improvement over its 2013 NOL of $40.2 million. ...
(Date:2/27/2015)...  Boston Scientific Corporation (NYSE: BSX ) ... Healthcare Conference on March 10 in Miami ... executive vice president and chief financial officer, and ... in a 25-minute question and answer session regarding the ... ET. Following a 5-minute break, a question and answer ...
(Date:2/27/2015)... KING OF PRUSSIA, Pa. , Feb. 27, 2015 ... part of its ongoing commitment to the global bleeding ... it is donating 2 million international units (IUs) of ... WFH is an international not-for- profit organization which has ... and other inherited bleeding disorders. The donation supports the ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3
... 15, 2011 The FDA today issued draft ... quality clinical studies in support of premarket approval ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Manufacturers submit ... These applications undergo the most stringent type of ...
... Astellas US, LLC ("Astellas") recently named Percival Barretto-Ko ... Affairs, a new position added to the company,s ... Yoshida, Barretto-Ko will be responsible for corporate planning, ... state government affairs. "This realignment brings ...
Cached Medicine Technology:FDA Seeks Comment on Proposed Guidelines for High-Quality Clinical Studies 2Astellas Expands Leadership Team With Senior Vice President of Corporate Strategy and Government Affairs 2
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an article ... To Steal Your Data , which stresses the ease with ... DIY phishing kit, or any kind of malware kit for ... point about how everyone’s cyber security is intertwined when it ... legitimate content management systems or blogs in order to install ...
(Date:2/28/2015)... 28, 2015 Javon Bea Mercy ... Harvard Hospital as stroke capable by the State of ... ambulance to Mercy Harvard Hospital. , The hospital was ... their ability to treat stroke according to national standards ... transporting stroke patients to bypass hospitals not designated as ...
(Date:2/28/2015)... February 28, 2015 The World Scout ... learning materials to potential EMTs and firefighters, recently announced ... as a way to raise charitable donations for age-related ... Medellin, Columbia, will be held on March 29, 2015; ... will begin at 3:30 p.m. , To participate ...
(Date:2/27/2015)... Wireless Analytics, an award-winning ... of the founders of the wireless expense ... within their CLEAN Platform™ (Communications Lifecycle Expense Analytics) ... newly developed Bell Mobility Data Loader enables unprecedented ... carrier’s business customers. , Wireless Analytics cites customer ...
(Date:2/27/2015)... 2015 Those who self-injure, ... misunderstood, misdiagnosed and therefore aren’t receiving effective ... Jacksonville-based addiction treatment center Lakeview Health ... acclaimed Lakeview Professional Lecture Series to counselors, ... this complicated condition. , “Self-injurious ...
Breaking Medicine News(10 mins):Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3Health News:Lakeview Health to Host Important Workshop Tackling the Rising Issue of ‘Cutters’ on March 27 2
... SILVER SPRING, Md., Aug. 3 Four simple ... of ongoing couples therapy can greatly increase chances for reconciliation ... largest clinical trial with couples to date, it shows that ... technique were 46.2 percent less than that of couples who ...
... , HATBORO, Pa., August 3 ... IFLG ), a leading technology provider of enterprise mobility solutions ... of a new mobility offering for healthcare providers, the InfoLogix ... enables medical professionals to access critical patient information at the ...
... research , MONDAY, Aug. 3 (HealthDay News) -- Common variants ... an increased risk of pancreatic cancer, according to U.S. researchers. ... cancer patients and more than 4,500 people without the disease. ... gene that produce the blood types A, B or AB ...
... , , BERKELEY HEIGHTS, N.J., ... ADAT ), a worldwide provider of secure ... announced that Medical Services of America, Inc., a ... equipment, headquartered in Lexington South Carolina, will implement ...
... , , , RIDGEFIELD, ... International Association for the Study of Lung Cancer,s 13th World ... of a Phase III clinical study of BIBW 2992 as ... epidermal growth factor receptor (EGFR) mutations. BIBW 2992 is ...
... , MOUNTAIN VIEW, Calif., Aug. 3 ... for the second quarter ended June 30, 2009. , , ... $5.0 million, compared to $16.5 million during the same period in 2008. ... million, compared to $30.8 million for the first six months of 2008. ...
Cached Medicine News:Health News:Therapy Technique Cuts Divorce/Separation Rate By Nearly 50 Percent 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 3Health News:Blood Type May Boost Pancreatic Cancer Risk 2Health News:Medical Services of America Selects Authentidate's Inscrybe Healthcare to Standardize Healthcare Order Process Management 2Health News:Medical Services of America Selects Authentidate's Inscrybe Healthcare to Standardize Healthcare Order Process Management 3Health News:Medical Services of America Selects Authentidate's Inscrybe Healthcare to Standardize Healthcare Order Process Management 4Health News:Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations 2Health News:Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations 3Health News:Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations 4Health News:Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations 5Health News:Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations 6Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 3Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 4Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 5Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 6Health News:MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 7
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: